Navigation Links
New England Journal of Medicine Publishes New Data on Gardasil,,Merck's Cervical Cancer Vaccine

at had a median duration of follow-up of 1.9 years. GARDASIL reduced the overall rate of CIN 2/3 or AIS caused by vaccine or non-vaccine HPV types by 12.2% (95% CI: -3.2%, 25.3%), compared with placebo. An analysis of overall population impact for the HPV 16 L1 VLP vaccine was conducted from study 005 that had a median duration of follow-up of 3.9 years. The HPV 16 L1 VLP vaccine reduced the overall incidence of CIN 2/3 caused by vaccine or non-vaccine HPV types by 32.7% (95% CI: -34.7%, 67.3%) through a median duration of follow-up of 1.9 years (fixed case analysis) and by 45.3% (95% CI: 10.9%, 67.1%), through a median duration of follow-up of 3.9 years (end of study). GARDASIL reduced the incidence of definitive therapy (e.g., loop electrosurgical excision procedure, laser conization, cold knife conization) by 16.5% (95% CI: 2.9%, 28.2%), and surgery to excise external genital lesions by 26.5% (95% CI: 3.6%, 44.2%), compared with placebo for all HPV-related diseases. These analyses were performed in the general population of women which includes women regardless of baseline HPV PCR status or serostatus. GARDASIL has not been shown to protect against the diseases caused by all HPV types and will not treat existing disease caused by the HPV types contained in the vaccine. The overall efficacy of GARDASIL, described above, will depend on the baseline prevalence of HPV infection related to vaccine types in the population vaccinated and the incidence of HPV infection due to types not included in the vaccine. Immunogenicity Assays to Measure Immune Response Because there were few disease cases in subjects naive (PCR negative and seronegative) to vaccine HPV types at baseline in the group that received GARDASIL, it has not been possible to establish minimum anti-HPV 6, anti-HPV 11, anti-HPV 16, and anti-HPV 18 antibody levels that protect against clinical disease caused by HPV 6, 11, 16, and/or 18. The immunogenicity of
'"/>




Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32

Related medicine technology :

1. Research on New Treatment for Neglected Disease Published in The New England Journal of Medicine
2. Landmark Study Published in the New England Journal of Medicine Shows Important Benefits of Eprodisate (KIACTA) Treatment for Patients with Amyloid A (AA) Amyloidosis
3. Statement by Philip Home Chairman of the RECORD Study Steering Committee and Professor of Diabetes Medicine at Newcastle University in England
4. Large Geographic Differences in EpiPen Prescriptions in the U.S., From the Journal of Allergy and Clinical Immunology
5. Positive Aggrastat Results Featured in the Journal of the American College of Cardiology
6. Peer Reviewed Journal Article Indicates Repros Proellex Exhibits Potential for New Approach to the Treatment and Prevention of Breast Cancer
7. New Study in Journal of Pediatrics Suggests Synagis (Palivizumab) May Reduce Subsequent Recurrent Wheezing in Preterm Infants
8. Genetics Journal Thimerosal/Autism Study the Best Science Drug Company Money Can Buy
9. Interim Analysis of Crinone Pregnancy Study to Be Published in American Society for Reproductive Medicine Journal
10. Nuvelo Announces Publication of Phase 2 rNAPc2 Study Results in Journal of American College of Cardiology
11. Trophos Publishes ALS Article in Journal of Pharmacology and Experimental Therapeutics
Post Your Comments:
(Date:7/29/2015)... July 29, 2015 WuXi PharmaTech (Cayman) Inc. ... and technology platform company serving the pharmaceutical, biotechnology and ... and the United States ... for the second-quarter of 2015 after the New York ... will be Friday morning, August 14, 2015 Shanghai time). ...
(Date:7/29/2015)... SAN DIEGO, July 29, 2015 Neurocrine Biosciences, Inc. (NASDAQ: ... ended June 30, 2015. For the second quarter of 2015, the ... per share, compared to a net loss of $13.4 million, or ... the six months ended June 30, 2015, the Company reported a ... compared to net loss of $25.2 million, or $0.35 loss per ...
(Date:7/29/2015)... July 29, 2015 Sangamo BioSciences, Inc. (NASDAQ: ... release its second quarter 2015 financial results after the ... release will be followed by a conference call at ... public via telephone and webcast. During the conference call, ... discuss other business matters. The conference call ...
Breaking Medicine Technology:WuXi PharmaTech Schedules Second-Quarter 2015 Earnings Release 2Neurocrine Biosciences Reports Second Quarter 2015 Results 2Neurocrine Biosciences Reports Second Quarter 2015 Results 3Neurocrine Biosciences Reports Second Quarter 2015 Results 4Neurocrine Biosciences Reports Second Quarter 2015 Results 5Neurocrine Biosciences Reports Second Quarter 2015 Results 6Neurocrine Biosciences Reports Second Quarter 2015 Results 7Neurocrine Biosciences Reports Second Quarter 2015 Results 8Neurocrine Biosciences Reports Second Quarter 2015 Results 9Sangamo BioSciences Announces Second Quarter 2015 Conference Call and Webcast 2
... Nov. 1, 2011 Cambrex Corporation (NYSE: ... will be released on Thursday, November 3, 2011 after ... host a conference call to discuss the third quarter ... Friday, November 4, 2011 at 8:30 a.m. Eastern Time ...
... Inc. (NASDAQ: HSIC ), the largest provider ... reported record financial results for the quarter ended September ... and related profits were lower this quarter than in ... meaningful commentary the Company will be discussing results including ...
Cached Medicine Technology:Henry Schein Reports Record Third Quarter Results 2Henry Schein Reports Record Third Quarter Results 3Henry Schein Reports Record Third Quarter Results 4Henry Schein Reports Record Third Quarter Results 5Henry Schein Reports Record Third Quarter Results 6Henry Schein Reports Record Third Quarter Results 7Henry Schein Reports Record Third Quarter Results 8Henry Schein Reports Record Third Quarter Results 9Henry Schein Reports Record Third Quarter Results 10Henry Schein Reports Record Third Quarter Results 11
(Date:7/30/2015)... ... July 30, 2015 , ... World Breast-Feeding ... to ensure their children have the nutrition required to grow into healthy adults. ... discount cards for many prescription pre-natal vitamins. , Folic Acid , Arguably one ...
(Date:7/29/2015)... (PRWEB) , ... July 30, 2015 , ... Drs. Hamstead ... doctors decided to add massage therapy to the offerings in the clinic; massage therapy ... spine. , Massage therapist Crystal Gaines has joined AlignLife of Simpsonville to work ...
(Date:7/29/2015)... ... 29, 2015 , ... If you’re a fan of Vietnamese banh mi sandwiches ... the Orange County Register , more than 465,000 pounds of mislabeled meat has ... does not mention any reported illnesses that have been connected to problems reportedly spotted ...
(Date:7/29/2015)... ... July 29, 2015 , ... In ... help with the problems of substance abuse that face today’s society, A Forever ... to come to their rehabilitation center. The facility, located in Southwest Michigan hosted ...
(Date:7/29/2015)... ... July 29, 2015 , ... VideoLink , ... Medical Center, located in New York, NY, selected the ReadyCam on-site video studio ... and scientists to immediately access worldwide TV and cable news networks and participate ...
Breaking Medicine News(10 mins):Health News:Medicationdiscountcard.com Encourages Pre-Natal Wellness in Time for World Breast-Feeding Week 2Health News:Medicationdiscountcard.com Encourages Pre-Natal Wellness in Time for World Breast-Feeding Week 3Health News:Medicationdiscountcard.com Encourages Pre-Natal Wellness in Time for World Breast-Feeding Week 4Health News:AlignLife of Simpsonville Hires Massage Therapist 2Health News:Three Important Product Liability Realities Offered In Light of News of Recent Product Recalls 2Health News:Three Important Product Liability Realities Offered In Light of News of Recent Product Recalls 3Health News:MADD Victim Services Specialist Visits A Forever Recovery Rehabilitation Facility 2Health News:Columbia University Medical Center Installs a VideoLink ReadyCam® Video Studio on Campus; Medical Experts Able to Appear on Live TV at a Moment's Notice 2Health News:Columbia University Medical Center Installs a VideoLink ReadyCam® Video Studio on Campus; Medical Experts Able to Appear on Live TV at a Moment's Notice 3
... disease among those vaccinated were no higher than in ... -- Rates of a rare neurodegenerative disease, Guillain-Barre syndrome, ... were no higher than among the general population, new ... noted after widespread swine flu vaccination in 1976, researchers ...
... ... ... 2,600 people is being sent to Mexico after an earthquake rocked the country last week. , ... 25,000 people have been affected by the earthquake with the worse damage in rural areas south ...
... 1871, Charles Darwin sparked debate that continues today when ... sexual selection. Sexual selection is Darwin,s theory that certain ... in competition among individuals for access to preferred mates ... to attract mates. Now, in a much expanded update ...
... ... ... After building a global leadership position developing mercury-free clean energy UV-LED solutions for an ... finalist for the 2010 TechAmerica Oregon Technology Awards. The award winners will be announced ...
... no social fear and appear open, friendly to all, ... -- Children with a rare condition called Williams syndrome ... prejudice, a new study shows. , The finding suggests ... racial stereotyping. , French and German researchers examined the ...
... grant from the Agency for Healthcare Research and Quality ... the comparative effectiveness of positron emission tomography (PET) and ... on the diagnosis and management of cancer patients, but ... , "Comparative effectiveness research is essential to the future ...
Cached Medicine News:Health News:Guillain-Barre Syndrome Very Rare After H1N1 Vaccine 2Health News:Guillain-Barre Syndrome Very Rare After H1N1 Vaccine 3Health News:ShelterBox Aid en route to Mexico Following Earthquake 2Health News:ShelterBox Aid en route to Mexico Following Earthquake 3Health News:Darwin was right 2Health News:Darwin was right 3Health News:Phoseon Technology Selected as Finalist for 2010 TechAmerica Oregon Technology Awards 2Health News:Phoseon Technology Selected as Finalist for 2010 TechAmerica Oregon Technology Awards 3Health News:Kids With Rare Condition Lack Racial Prejudice 2Health News:SNM receives grant from AHRQ for comparative effectiveness research 2
Pocket-sized instrument with 2.5X magnification....
Durable, simple and easy to use. Lightweight, base can detach and be used as a penlight....
All Keeler otoscopes have bright halogen illumination for clear and accurate visualization of aural canal. Lithium-ion batteries with quick recharge capability. Ring rheostat for fine control of il...
... offer patented Sensomatic® handles that ... up and switch off when ... of light from 3.5V xenon ... of examination area. Used ...
Medicine Products: